Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.SSE: 605016

(605016)"Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."Announcement on Obtaining Registration Approval from the China Securities Regulatory Commission for the Application for Issuance of Convertible Corporate Bonds to Unspecified Investors

· Issued by Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 605016 · · 1 page · Chinese

Summary by 6ix AI

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. has announced that it received approval from the China Securities Regulatory Commission for its application to issue convertible corporate bonds to unspecified investors.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/605016shandong-bailong-chuangyuan-bio-tech-co-ltdannouncement-on-obtaining-registration-approval-from-the-china-securities-regulatory-commission-for-the-application-for-issuance-of-convertible-corporate-bonds-to-unspecified-investors

Release

Announcement on Obtaining Registration Approval from the China Securities Regulatory Commission for the Application for Issuance of Convertible Corporate Bonds to Unspecified Investors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. on 6ix

Story so far

Earlier from Shandong Bailong Chuangyuan Bio-Tech

All Shandong Bailong Chuangyuan Bio-Tech news releases